1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with vendex in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (vendex) | Trials (vendex) | Recent Studies (post-2010) (vendex) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 10,698 | 1,283 | 5,830 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonopoulou, S; Athanasopoulos, S; Fragopoulou, E; Milias, GA; Nomikos, T | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and vendex
Article | Year |
---|---|
Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers.
Topics: Adult; C-Reactive Protein; Complement C3; Creatine Kinase; Elbow Joint; Exercise; Fibrinogen; Humans; Inflammation; L-Lactate Dehydrogenase; Leukocyte Count; Male; Muscle Contraction; Muscle, Skeletal; Platelet Activating Factor; Torque | 2005 |